Take control with Dexcom G6 and stay one step ahead of diabetes. Receive high/low glucose alerts and alarms.
Monitor glucose activity in real-time with a small sensor, transmitter and a Dexcom Receiver. Receive glucose readings every 5 minutes.
The Dexcom G6 features an overall MARD†of 9.0%1,2 and demonstrates consistent performance even when glucose levels may be rapidly falling or rising1.
The Dexcom G6 is a mobile CGM system including customizable alerts and the ability to share glucose data with up to 10 loved ones.††
No need to calibrate with a blood glucose meter, eliminating the need for fingersticks.‡
‡ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Wearable for up to 10 days of use.
The Dexcom G6 sensor prevents clinically significant interference from acetaminophen.§3
One-button push insertion.
Receive a 20-minute advance warning of a potential severe hypoglycemic event (55 mg/dL).
Alerts can be customized for two periods of time within 24 hours (e.g., day and night schedules).
Please note the form below is only intended for new customers. If you are a current Dexcom customer, please click here for more information.
Who is covered under Medicare?
According to CMS, therapeutic CGM may be covered by Medicare when all of the following criteria are met:
In order to be included in this category, the system must be defined as therapeutic CGM, meaning you can make treatment decisions using the device.
* For a full description of Medicare coverage criteria, please visit here
*must meet Medicare eligibility coverage criteria
† MARD is a statistical measure of accuracy
†† Separate Follow App required.
‡ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
§ G6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every 6 hours. Taking a higher dose may affect the G6 readings.
|| Data on file.
1 Dexcom G6 CGM System User Guide, 2019.
2 Shah V LL, Wadwa P, et al. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technology and Therapeutics. 2018;20(6).
3 Calhoun P, Johnson TK, Hughes J, Price D, Balo AK. Resistance to Acetaminophen Interference in a Novel Continuous Glucose Monitoring System. J Diabetes Sci Technol. 2018:1932296818755797.
BRIEF SAFETY STATEMENT Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.